NCT03414684 Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03410875 A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03392246 A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03391362 Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases Status ACTIVE_NOT_RECRUITING Phase NA
NCT03367247 BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal Status COMPLETED Phase NA
NCT03364673 Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer Status COMPLETED Phase NA
NCT03361852 Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03341936 Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03340532 HealthSmart: Promoting Healthy Lifestyles for Young Adult Cancer Survivors Using Educational Videos Status COMPLETED Phase NA
NCT03333616 Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03328091 Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen) Status COMPLETED Phase NA
NCT03319901 Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03316599 Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1